Dr Mark Treherne has 30 years' experience in the discovery of novel treatments for and the diagnosis of diseases with unmet medical needs. He has helped to raise over £370 million, mostly for early-stage life sciences companies and served on the boards of multiple therapeutics, research services, research tools and diagnostics companies worldwide. He has worked with teams to out licence therapeutic assets for upfront and contingent payments exceeding £1.5 billion.